Search Results 681-690 of 18612 for fasting

1. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

   Fasting serum glucose < 1.5 x ULN obtained ≤ 7 days prior to registration; Fasting serum cholesterol ≤ 300 mg/dL OR ≤ 7.75 mmol/L AND fasting ...

2. Patient Honors Her Liver Donor and Faith in New Book - Mayo Clinic News Network

   Lyons turned to her church for support, where her pastor and fellow members prayed and fasted, hoping for an answer. On the last day of a 30-day fast, her ...

3. Enhancing Adaptations to Exercise - Clinical Trials

   Regular use of omega-3 nutritional supplements · Diabetes or fasting plasma glucose > or equal to 126 mg/dL · Anemia (female subjects hemoglobin of <11 g/dl and ...

4. Omega-3 Fatty Acids To Combat Sarcopenia - Mayo Clinic

   Fasting plasma glucose ≥126 mg/dL; Active coronary artery disease; Participation in structured exercise (>3 times per week for 30 minutes or longer); Smoking ...

5. A Study of Study of Free-Breathing Magnetic Resonance Elastography (MRE) of the Liver in Healthy Volunteers and Its Longitudinal Application in Patients with Chronic Liver Diseases - Mayo Clinic

   Participant fasting four hours before MRI scanning time. Enrolled subjects will have hepatic MRI exam at study visits 1 and 2.Second visit to be completed ...

6. Hand-foot-and-mouth disease - Diagnosis & treatment - Mayo Clinic

   This is called fasting. You also can get ready by making a list of: Your child's symptoms. Include any that don't seem related to the reason for your ...

7. A Study to Examine the Molecular Mechanisms of Acute Effects of Resistance Exercise - Mayo Clinic

   For all participants - cardiovascular, metabolic (type 2 diabetes, fasting plasma glucose at or above 110 mg/dL and untreated hypo- or hyperthyroidism) or ...

8. Renal Cell Carcinoma Clinical Trials - Mayo Clinic Research

   By managing the adverse side effects of ICI treatments in select cancer patients, the study will assess the effect of immunotherapy plus the Xentigen fasting ...

9. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

   baseline fasting glucose >150 mg/dL (8.3 mmol/L) or high glycosylated hemoglobin (Hb)A1c, suggesting poorly controlled diabetes - Participants who are on a ...

10. Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes - Mayo Clinic

    T2DM, or impaired fasting glucose. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...